Hims & Hers Health (HIMS) FY2023 results: revenue $872 million, up 65.5% on the year
Hims & Hers Health, Inc. (HIMS) reported revenue of $872 million for fiscal 2023, the year ended 31 December 2023, up 65.5% on the year before. Net income was -$24 million, and diluted earnings per share $-0.11. The figures are the company's own, from the 10-K it filed with the SEC on 26 February 2024.
Revenue
$872 million
+65.5% on the year
FY2019FY2023
Operating margin
-3.4%
-13.0% a year earlier
FY2019FY2023
Net income
-$24 million
FY2019FY2023
Diluted EPS
-$0.11
FY2019FY2023
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2023
FY2022
FY2021
On the year
Last 8 years
Operating cash flow
73.5
-26.5
-34.4
Capital expenditure
26.5
7.2
n/a
+268.1%
Free cash flow
47.0
-33.7
n/a
Free cash flow margin
5.4%
-6.4%
n/a
Cash from investing
-12.1
34.7
-156
Cash from financing
-11.5
-33.1
235
Depreciation and amortisation
9.5
7.5
4.1
+27.3%
Share-based compensation
66.1
42.8
67.2
+54.3%
Buybacks
2.0
0.0
0.0
Diluted shares, weighted
209m
205m
187m
+2.4%
Balance sheet
$ million
FY2023
FY2022
FY2021
On the year
Last 8 years
Shareholders' equity
344
312
335
+10.4%
Redeemable equity
n/a
n/a
0.0
Debt
0.0
0.0
0.0
Operating lease liabilities
8.7
3.6
4.1
+137.5%
Other liabilities
88.5
51.0
81.8
+73.7%
Total liabilities and equity
441
366
421
+20.4%
Fixed assets
n/a
3.0
2.2
Goodwill
111
111
111
0.0%
Intangible assets
18.6
21.8
25.9
-15.0%
Investments
124
133
175
-6.4%
Cash and equivalents
96.7
46.8
71.8
+106.7%
Receivables
6.7
3.9
4.1
+71.8%
Inventory
22.5
21.6
13.6
+4.2%
Other assets
61.6
25.5
16.7
+141.2%
Total assets
441
366
421
+20.4%
10-K for the year ended 31 December 2023, filed 26 February 2024: the filing.